Range of Motives Likely Behind Surge in Drugmaker Contract Pharmacy Changes, Say Provider Advisers

Jason Reddish, a principal at Powers Law who represents covered entities, said drugmakers were "emboldened" by recent federal court decisions to issue contract pharmacy restrictions.
A surge of recent drug manufacturer contract pharmacy policy changes may be driven by recent legal developments, new state laws, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Scoping 340B Referral Capture Opportunity: It’s Bigger Than You Think

SPONSORED CONTENT

Imagine the services you could offer to the community your facility serves if you had additional funding. If you’re a 340B covered entity (CE), referral capture might just pave the way to securing those much-needed funds.

The 340B program provides essential funding

Read More »

TPA Fees: Before You Sign on the Dotted Line

SPONSORED CONTENT

As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important than ever for covered entities to have a firm grasp and understanding of the fees charged by their Third Party Adminisrators (TPAs) for their contract pharmacies. Whether it is

Read More »

Consolidated Service Centers and 340B: Can they Coexist?

SPONSORED CONTENT

Consolidated Service Centers (CSCs) centralize many pharmacy services along with the inventory of a health system and capture significant savings through processes such as strategic buys, standardization, and low units of measure distribution, just to name a few. But the most frequently asked question by

Read More »

PBM is not a 4-letter word: How an independent PBM and an integrated pharmacy strategy provides value for your organization

SPONSORED CONTENT

Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. Creating an integrated pharmacy strategy can

Read More »

Spring Cleaning of Your 340B Program

SPONSORED CONTENT

As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to conduct a thorough review and update of their 340B program. Ensuring your program’s compliance and efficiency is akin to spring cleaning—tidying up, organizing, and preparing for the year ahead. Below,

Read More »

U.S. Drug Spending Increased 14 Percent in 2023; Clinic, Hospital Trends Diverge

Eric Tichy led research with seven of his colleagues that examined U.S. drug spending trends in 2023.
Drug spending increased by 13.6% in 2023 to $722.5 billion, according to recent research. It found divergent trends for clinic [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Navigating State-Level Regulations to Safeguard Your 340B Program

SPONSORED CONTENT

While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of complexity. Covered entities (CEs) must be vigilant in understanding how these state laws can impact their operations to avoid potential compliance pitfalls. We have outlined a few

Read More »

340B Program Critics, Supporters Target States 

ALEC, a conservative legislative group that receives drug industry funding, is advocating against state 340B legislation. Provider groups have criticized the campaign and launched their own efforts in support of 340B state bills.
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kansas is Fifth State to Enact 340B Contract Pharmacy Access Law

Kansas Gov. Laura Kelly speaks at a rally.
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill on April 24 that contains a provision to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill late Wednesday that contains a provision to prohibit drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live